AXD2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heron Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.3336 EUR 12.25% Market Closed

Market Cap: €50.2m

	Heron Therapeutics Inc F:AXD2	US
	NowVertical Group Inc XTSX:NOW	CA
	NetObjects Inc OTC:NETO	US
B	Buzzi Unicem SpA F:UCM	IT
Z	Zenovia Digital Exchange Corp OTC:ZDEC	US
V	VS Industry Bhd KLSE:VS	MY

Profitability Summary

Heron Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

70%

Strong 3Y Average Gross Margin

69%

Gross Margin is Increasing

45% > 70%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-22%

Operating Margin is Increasing

-98% > -15%

Negative Net Margin

-23%

Negative 3Y Average Net Margin

-26%

Net Margin is Increasing

-97% > -23%

Negative Free Cash Flow Margin

-8%

Negative 3Y Average Free Cash Flow Margin

-20%

Free Cash Flow Margin is Increasing

-82% > -8%

Exceptional ROE

335%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-19%

ROIC is Increasing

-82% > -12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.